Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone (BV-CHEP) for the treatment of aggressive adult T-cell leukaemia/lymphoma

IF 3.8 2区医学 Q1 HEMATOLOGY

British Journal of Haematology Pub Date : 2025-06-03 DOI:10.1111/bjh.20177

Christopher Dittus, Matthew J. Weinstock, Jeffrey Barnes, Jose Sandoval-Sus, Natalie S. Grover, Anne Beaven, Kelly Hoye, Anthony Shelton, Xianming Tan, Maya D. Srinivasan, Areej El-Jawahri, Shayna Sarosiek, J. Mark Sloan

引用次数: 0

Abstract Image

查看原文本刊更多论文

一项评估brentuximab vedotin联合环磷酰胺、阿霉素、依托泊苷和强的松（BV-CHEP）治疗侵袭性成人t细胞白血病/淋巴瘤的多中心试点研究的最终结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

British Journal of Haematology 医学-血液学

CiteScore

8.60

自引率

4.60%

发文量

565

审稿时长

1 months

期刊介绍： The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.